BISPECIFIC DOMAIN ANTIBODIES TARGETING SERUM ALBUMIN AND GLP-1 OR PYY
摘要
<p>Drug fusions and conjugates that contain an incretin therapeutic or diagnostic agent that is fused or conjugated to an antigen-binding fragment of an antibody that binds serum albumin. The conjugates and fusion have a longer in vivo half life in comparison with the unconjugated or unfused therapeutic or diagnostic agent.</p>
申请公布号
SG157423(A1)
申请公布日期
2009.12.29
申请号
SG20090079195
申请日期
2005.11.30
申请人
DOMANTIS LIMITED
发明人
HOLMES, STEVE;HOLT, LUCY, J.;JESPERS, LAURENT, S.;TOMLINSON, IAN, M.